MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 22, Issue 13, Pages 1719-1731
Publisher
SAGE Publications
Online
2016-09-02
DOI
10.1177/1352458516667568
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
- (2016) Frédéric Sedel et al. NEUROPHARMACOLOGY
- Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios
- (2015) Ali Manouchehrinia et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- High doses of biotin in chronic progressive multiple sclerosis: A pilot study
- (2015) Frédéric Sedel et al. Multiple Sclerosis and Related Disorders
- New Multiple Sclerosis Phenotypic Classification
- (2014) Fred D. Lublin EUROPEAN NEUROLOGY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS
- (2013) J. Hobart et al. NEUROLOGY
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study
- (2012) Nilika G. Wijeratne et al. PATHOLOGY
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
- (2009) Bruce D Trapp et al. LANCET NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More